Resmed RMD
NYSE RMD
$253.12 +6.91 (+2.81%)
At close: Oct 22, 2026 · 4:00 PM EDT

Resmed (RMD) Liabilities from Discontinued Operations (2026)

Updated

Resmed (RMD) reported Liabilities from Discontinued Operations of $41.16 million for fiscal Q4 2026 (quarter ended Jun 30, 2026).

Analysis

Resmed (RMD) Liabilities from Discontinued Operations (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 250.06 Bn 229.21 Bn 4.88 Bn
2 Abbott Laboratories 177.62 Bn 148.71 Bn 7.27 Bn
3 Danaher 161.58 Bn 145.40 Bn 3.61 Bn
4 Intuitive Surgical 153.84 Bn 134.26 Bn 2.08 Bn
5 Medtronic 123.63 Bn 89.50 Bn 6.34 Bn
6 Stryker 117.79 Bn 103.90 Bn 4.50 Bn
7 Boston Scientific 66.71 Bn 61.72 Bn 3.85 Bn
8 Becton Dickinson 54.60 Bn 51.75 Bn 2.32 Bn
9 Edwards Lifesciences 51.95 Bn 36.07 Bn 1.35 Bn
10 Resmed 36.51 Bn 30.58 Bn 861.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.16 Mn
API Access

Resmed Liabilities from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-from-discontinued-operations&ticker=RMD&period=max&api_key=YOUR_API_KEY